Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 5 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

Recs

0
Player Avatar dongreene22 (< 20) Submitted: 5/4/2011 1:49:47 AM : Outperform Start Price: $9.26 SPPI Score: +23.80

takeover target

Featured Broker Partners


Advertisement